Rein Therapeutics, Inc. Operating Leases, Rent Expense
Rein Therapeutics, Inc. (RNTX) reported Operating Leases, Rent Expense of $494.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-04-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2018-04-02
- Rein Therapeutics, Inc. operating leases, rent expense for the quarter ending 2017-12-31 was $127.00K, a 9.48% increase year-over-year.
- Rein Therapeutics, Inc. operating leases, rent expense for the quarter ending 2017-09-30 was $127.00K, a 19.81% increase year-over-year.
- Rein Therapeutics, Inc. operating leases, rent expense for the quarter ending 2017-06-30 was $120.00K, a 14.29% increase year-over-year.
- Rein Therapeutics, Inc. operating leases, rent expense for the quarter ending 2017-03-31 was $120.00K.
- Rein Therapeutics, Inc. operating leases, rent expense for fiscal 2017 was $494.00K, a 14.35% increase from fiscal 2016.
- Rein Therapeutics, Inc. operating leases, rent expense for fiscal 2016 was $432.00K, a 67.44% increase from fiscal 2015.
- Rein Therapeutics, Inc. operating leases, rent expense for fiscal 2015 was $258.00K.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month |
|---|---|---|---|---|
| 2017-12-31 | $127.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $254.00K derived: sum of 2 quarters · filed 2018-04-02 | $374.00K derived: sum of 3 quarters · filed 2018-04-02 | $494.00K 10-K · filed 2018-04-02 |
| 2017-09-30 | $127.00K 10-Q · filed 2017-11-09 | $247.00K derived: sum of 2 quarters · filed 2017-11-09 | $367.00K 10-Q · filed 2017-11-09 | $483.00K derived: sum of 4 quarters · filed 2018-04-02 |
| 2017-06-30 | $120.00K 10-Q · filed 2017-08-10 | $239.00K 10-Q · filed 2017-08-10 | $356.00K derived: sum of 3 quarters · filed 2018-04-02 | $462.00K derived: sum of 4 quarters · filed 2018-04-02 |
| 2017-03-31 | $120.00K derived: 10-K 12 month − 3 quarters · filed 2018-04-02 | $236.00K derived: sum of 2 quarters · filed 2018-04-02 | $342.00K derived: sum of 3 quarters · filed 2018-04-02 | $447.00K derived: sum of 4 quarters · filed 2018-04-02 |
| 2016-12-31 | $116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $222.00K derived: sum of 2 quarters · filed 2018-04-02 | $327.00K derived: sum of 3 quarters · filed 2018-04-02 | $432.00K 10-K · filed 2018-04-02 |
| 2016-09-30 | $106.00K 10-Q · filed 2017-11-09 | $211.00K derived: sum of 2 quarters · filed 2017-11-09 | $316.00K 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $105.00K 10-Q · filed 2017-08-10 | $211.00K 10-Q · filed 2017-08-10 | ||
| 2015-12-31 | $258.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |